pain at injection site; hardness at injection site; Swelling at injection site; itching at injection site; bruised spots under both underarms/then left bruise on arm/My arm also has bruise marks; underarm pain started as if my glands were swollen; underarm pain started as if my glands were swollen; arm pain; the areas are still tender; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 at 17:45 as dose 4 (booster), single (Lot number: GH9702) at the age of 59 years, in left arm for covid-19 immunisation; influenza vaccine inact sag 4v (FLUCELVAX QUAD), on 21Sep2022 as dose 1, single (Lot number: 942371), in right arm for immunisation. The patient's relevant medical history included: "Migraine" (unspecified if ongoing), notes: Other medical history: Migraine, gastrointestinal issues; "gastrointestinal issues" (unspecified if ongoing), notes: Other medical history: Migraine, gastrointestinal issues. Concomitant medication(s) included: LYRICA; DEXILANT; ANTIVERT [MECLOZINE HYDROCHLORIDE]; FIORICET; BENTYL; CARA [CLOTRIMAZOLE]. Past drug history included: Known allergies: erythromycin, reaction(s): "drug allergy", notes: Known allergies Erythromycin; Known allergies: celebrex, reaction(s): "drug allergy", notes: Known allergies Celebrex. Vaccination history included: Covid-19 vaccine (primary immunization series completed but manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (DOSE: 3 (first booster)), for Covid-19 immunization. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 21Sep2022 at 20:45, outcome "recovering", described as "Swelling"; PAIN IN EXTREMITY (non-serious) with onset 21Sep2022 at 20:45, outcome "recovering", described as "arm pain"; CONTUSION (non-serious) with onset 21Sep2022 at 20:45, outcome "recovering", described as "bruised spots under both underarms/then left bruise on arm/My arm also has bruise marks"; VACCINATION SITE INDURATION (non-serious) with onset 21Sep2022 at 20:45, outcome "recovering", described as "hardness at injection site"; PRURITUS (non-serious) with onset 21Sep2022 at 20:45, outcome "recovering", described as "itching"; VACCINATION SITE PAIN (non-serious) with onset 21Sep2022 at 20:45, outcome "recovering", described as "pain at injection site"; TENDERNESS (non-serious) with onset 21Sep2022 at 20:45, outcome "not recovered", described as "the areas are still tender"; AXILLARY PAIN (non-serious), LYMPHADENOPATHY (non-serious) all with onset 21Sep2022 at 20:45, outcome "recovering" and all described as "underarm pain started as if my glands were swollen". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site pain, vaccination site induration, vaccination site swelling, pruritus, contusion, axillary pain, lymphadenopathy, pain in extremity, tenderness.  Additional information: Patient had experienced swelling, itching, pain and hardness at injection site for five days afterwards. Pain persisted, then left bruise on arm. Then afterwards underarm pain started as if her glands were swollen but patient noticed on Sunday (02Oct) that she was now have bruised spots under both underarms where the arm pain was. The pain was better, but the spots aren't gone, and the areas are still tender. Her arm also had bruise marks. Adverse events start date was 21Sep2022 and start time was 08:45 PM. Treatment for AE was not provided. Patient known allergies was erythromycin and celebrex and other medical history reported as migraine and gastrointestinal issues. Patient received other medications in two weeks was Lyrica, Dexilant, Antivert, Fioricet, Bentyl, Cara. COVID test type post vaccination: Nasal Swab, COVID test name post vaccination: Clinitest, COVID test date: 08Oct2022, COVID test result: Negative